0
Special Features: Patient-Centered Medical Homes
Pharmacogenomics in a community pharmacy: ACT now
Lisa Padgett, PharmD; Shanna O'Connor, PharmD, BCPS; Mary Roederer, PharmD, CPP, BCPS; Howard McLeod, PharmD; Stefanie Ferreri, PharmD, CDE
J Am Pharm Assoc. 2011;51:189-193. doi:10.1331/JAPhA.2011.10178

Abstract

Objective  To highlight the opportunity for community pharmacists to provide pharmacogenomic testing and counseling.

Data sources  Peer-reviewed pharmacy literature.

Summary  Pharmacists practicing in community pharmacy are accustomed to optimizing drug therapy through various medication therapy management programs. They use patient-specific information obtained from the patient and their prescribers to cater patient-specific drug regimens. Pharmacogenomics is rapidly evolving, and this field can help optimize medication therapy using an individual's genetic code to identify opportunities for increased or decreased adverse effects or changes in efficacy. Pharmacogenomic testing technology has made conducting pharmacogenomic testing in community pharmacies possible. Pharmacists must arm themselves with the knowledge and skills specific to pharmacogenomics in order to fully integrate this expanding area into patient care and turn this into a great opportunity.

Conclusion  Advances in knowledge and technology regarding pharmacogenomics coupled with the overwhelming access and use of a community pharmacist by patients provides a tremendous opportunity for community pharmacists to lay claim to the field of pharmacogenomics. Pharmacists are able and needed to provide testing, evaluate results, and offer patient and prescriber education for pharmacogenomics. Pharmacists must take steps to assess the entire clinical picture and use pharmacogenomics where appropriate to optimize drug therapy.

Sign In
APhA Members 
Welcome to JAPha.org! Please log in below using your APhA username and password. If you need to update your account information, please go to Pharmacists.org and login using your current credentials.
Username
Password


Forgot your password?
Not a Subscriber
New to JAPhA? Become an APhA member to receive a full subscription to both the print and online editions.

OR

Register for a FREE limited account to benefit from personalization features such as alerts.

References

Roederer MW. Pharmacists and pharmacogenetics.  Am J Health Syst Pharm.  2009;66:1256–7.[PubMed][CrossRef]
 
Grice GR, Seaton TL, Woodland AM, McLeod HL. Defining the opportunity for pharmacogenetic intervention in primary care.  Pharmacogenomics.  2006;7:61–5.[PubMed]
 
 Food and Drug Administration.  Table of pharmacogenomic biomarkers in drug labels. Accessed at www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm083378.htm, January 10,  2011.
 
McClain MR, Palomaki GE, Piper M, Haddow JE. A rapid-ACCE review of CYP2C9 and VKORC1 alleles testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding.  Genet Med.  2008;10:89–98.[PubMed]
 
Klein TE, Altman RB, Eriksson N, et al.  Estimation of the warfarin dose with clinical and pharmacogenetic data.  N Engl J Med.  2009;360:753–64.[PubMed]
 
Mega JL, Close SL, Wiviott SD, et al.  Cytochrome p-450 polymorphisms and response to clopidogrel.  N Engl J Med.  2009;360:354–62.[PubMed]
 
Chung WH, Hung SI, Hong HS, et al.  Medical genetics: a marker for Stevens-Johnson syndrome.  Nature.  2004;428:486.[PubMed]
 
Hung SI, Chung WH, Jee SH, et al.  Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.  Pharmacogenet Genomics.  2006;16:297–306.[PubMed]
 
Department of Health and Human Services.  Realizing the potential of pharmacogenomics: opportunities and challenges. Accessed at http://oba.od.nih.gov/oba/SACGHS/reports/SACGHS_PGx_report.pdf, January 10,  2011.
 
Carroll NV. Do community pharmacists influence prescribing? J Am Pharm Assoc.  2003;43:612–21.
 
Roughead L, Semple S, Vitry AI. Pharmaceutical care services: a systematic review of published studies, 1990-2003, examining effectiveness to improve patient outcomes.  Int J Pharm Pract.  2005;13:53–70.
 
Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes.  Cochrane Database Syst Rev.  2010;(7):CD000336.
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Please read the other comments before you post yours. Comments are moderated and will appear on the site at the discertion of the editorial staff.
* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content

Customize your page view by dragging & repositioning the boxes below.

JAPhA Articles
Advertisement
 
  • Print
  • PDF Download
  • Email
  • Share
  • Get Citation
  • Submit Comment
  • Article Alerts
    Please Wait... Processing your request... Please Wait.
    You must sign in to sign-up for alerts.

    Please confirm that your email address is correct, so you can successfully receive this alert.

  • Letters To Editor
  • Reprints